Author:
Jiang Jiuzhou,Pan Hao,Li Mobai,Qian Bao,Lin Xianfeng,Fan Shunwu
Abstract
AbstractOsteosarcoma is the most common bone malignancy, with the highest incidence in children and adolescents. Survival rate prediction is important for improving prognosis and planning therapy. However, there is still no prediction model with a high accuracy rate for osteosarcoma. Therefore, we aimed to construct an artificial intelligence (AI) model for predicting the 5-year survival of osteosarcoma patients by using extreme gradient boosting (XGBoost), a large-scale machine-learning algorithm. We identified cases of osteosarcoma in the Surveillance, Epidemiology, and End Results (SEER) Research Database and excluded substandard samples. The study population was 835 and was divided into the training set (n = 668) and validation set (n = 167). Characteristics selected via survival analyses were used to construct the model. Receiver operating characteristic (ROC) curve and decision curve analyses were performed to evaluate the prediction. The accuracy of the prediction model was excellent both in the training set (area under the ROC curve [AUC] = 0.977) and the validation set (AUC = 0.911). Decision curve analyses proved the model could be used to support clinical decisions. XGBoost is an effective algorithm for predicting 5-year survival of osteosarcoma patients. Our prediction model had excellent accuracy and is therefore useful in clinical settings.
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Mirabello, L., Troisi, R. J. & Savage, S. A. Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the surveillance, epidemiology, and end results program. Cancer 115, 1531–1543. https://doi.org/10.1002/cncr.24121 (2009).
2. Ottaviani, G. & Jaffe, N. The epidemiology of osteosarcoma. Cancer Treat Res. 152, 3–13. https://doi.org/10.1007/978-1-4419-0284-9_1 (2009).
3. Friebele, J. C., Peck, J., Pan, X., Abdel-Rasoul, M. & Mayerson, J. L. Osteosarcoma: A meta-analysis and review of the literature. Am. J. Orthop. (Belle Mead N.J.) 44, 547–553 (2015).
4. Anderson, M. E. Update on survival in osteosarcoma. Orthop. Clin. N. Am. 47, 283–292. https://doi.org/10.1016/j.ocl.2015.08.022 (2016).
5. Nathan, S. S. & Healey, J. H. Demographic determinants of survival in osteosarcoma. Ann. Acad. Med. Singap. 41, 390–399 (2012).
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献